Upstate Active Clinical Trials

Study Title:

Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

What is the purpose of the study?

Lab study to develop a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia.

Upstate Institutional Review Board (IRB) Number:

250590

Study/Protocol ID:

AALL08B1

Study Phase:

N/A

Patient Age Group:

Children

Principal Investigator:

Karol H Kerr, MD

ClinicalTrials.Gov ID:

NCT01629745

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Beatriz Kovar
Phone: 315-464-7232
Email: kovarb@upstate.edu

Return to Previous Page || Search Again